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Abstract
Vitamin D receptor (VDR) gene polymorphisms have been associated with susceptibility to several diseases, including type 1 diabetes (T1D),
type 2 diabetes (T2D), and various infections. The study investigated whether VDR gene polymorphisms inﬂuence nasal carriage of
Staphylococcus aureus in individuals with T2D, an important source for bloodstream, surgical site and other nosocomial infections. In 173
patients with T2D genotyped for the VDR gene polymorphisms on FokI (rs10735810) F>f, BsmI (rs1544410) B>b, ApaI (rs7975232) A>a, and
TaqI (rs731236) T>t, a nasal swab was obtained to detect colonization by S. aureus. A repeat swab was obtained in 162/173 subjects for the
estimation of persistent S. aureus carriage. The prevalence of S. aureus nasal colonization was 19.7% and of persistent carriage was 8.6%.
Nasal colonization by S. aureus was more common in individuals with FokI f allele than F allele (p 0.05; OR 1.69, 95% CI 1.00–2.89) and
individuals with FokI ff genotypes were more frequently colonized than those with FokI FF and Ff genotypes combined (p 0.03; OR 2.61, 95%
CI 1.14–5.99). The presence of the FokI f allele was related to higher rates of S. aureus persistent nasal colonization (p 0.002; OR 3.53, 95%
CI 1.56–7.98), and individuals with a FokI ff genotype were more often persistent carriers than those with FokI FF and Ff genotypes combined
(p <0.001; OR 7.32, 95% CI 2.39–22.41). This study is the ﬁrst, to our knowledge, to show an association between FokI polymorphism in the
VDR gene and nasal carriage of S. aureus in individuals with T2D.
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Introduction
The vitamin D endocrine system has pleiotropic effects on
calcium and bone metabolism as well as on the immune
system. The active form of vitamin D (1a,25-dihydroxyvitamin
D3) exerts its effects by binding to vitamin D receptor (VDR),
which has been identiﬁed in tissues with no direct role in
calcium and bone metabolism such as pancreatic b cells and in
cells of the immune system (T and B lymphocytes, monocytes
and macrophages) [1–3]. Polymorphisms in the human VDR
gene have been associated with susceptibility to various
diseases, including type 2 diabetes (T2D), although the ﬁndings
differ from one population to another and among several
bacterial and viral infections [4–16].
Staphylococcus aureus is a major pathogen in both
community-acquired and hospital-acquired infections. It often
colonizes the host and lives as a commensal of the human
nose. Approximately 10–40% of people tested as outpatients
or on admission have nasal carriage of S. aureus. Colonizing
strains may serve as endogenous reservoirs for clinical
infections or may spread to other patients. Several studies
have shown that elimination of S. aureus carriage in the
anterior nares reduces the incidence of S. aureus infections
[17,18].
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It has been suggested that mechanisms leading to S. aureus
nasal colonization are multifactorial with host’s immune
response being the most important [18–21]. In this context,
VDR gene polymorphisms may determine the likelihood of
persistent infection or colonization with S. aureus, because
vitamin D has been shown to play an important role in the
host’s immune response, especially on macrophage activation
and differentiation [14–22].
Clinicians have generally believed that patients with diabetes
are considered to be more susceptible to infections and these
are usually more severe than in patients without diabetes
[23,24]. Although VDR gene polymorphisms are related both
with T2D and susceptibility to infection, to date no study has
investigated potential links between VDR gene polymorphisms
on the one hand and T2D and S. aureus disease or carriage on
the other.
In this study we investigated, for the ﬁrst time in a Greek
population, whether the four most commonly studied poly-
morphisms in the VDR gene, namely FokI F>f, BsmI B>b, ApaI
A>a, and TaqI T>t are associated with colonization and
persistent carriage of S. aureus in individuals with T2D.
Materials and Methods
Study population
The study group consisted of a cohort of 173 patients with
T2D, followed up at the outpatient diabetic clinic of the
Department of Internal Medicine, University Hospital of
Heraklion, Crete, Greece over a 3-year period (2009–2011).
Diagnosis of T2D followed the American Diabetes Association
guidelines [25].
Staphylococcus aureus isolation, identiﬁcation and
antimicrobial susceptibility testing
Nasal specimens were obtained by rotating a sterile ﬁbre--
tipped swab four times in both anterior nares of each enrolled
individual. The swabs were immediately placed in Amies
transport medium (BioMerieux, Marcy L’Etoile, France) and
kept at 4°C before being inoculated onto mannitol salt agar
and Columbia agar with 5% sheep blood. The culture plates
were incubated at 36°C for 48 h. Staphylococcus aureus was
identiﬁed on the basis of colony morphology, Gram stain,
catalase test, coagulase test and the API 20 Staph system
(BioMerieux). A second nasal swab culture was obtained after
a minimum interval of 3 months. Subjects were classiﬁed as
persistent carriers if both cultures were positive, as non-
carriers if both cultures were negative, and as intermittent
carriers in cases where one culture was positive and the other
was negative. Individuals with a single nasal swab available were
excluded from further analysis of persistent carriage.
Genomic DNA extraction
Peripheral blood was collected in EDTA-containing tubes.
Genomic DNA was isolated from leucocytes using the
commercial kit PUREGENE (Gentra systems, Minneapolis,
MN, USA) according to the manufacturer’s protocol.
Extracted DNA was stored at 20°C until use.
VDR genotyping
Polymerase chain reaction and restriction fragment length
polymorphism were performed for genotyping of single
nucleotide substitutions at positions FokI, BsmI, ApaI and TaqI
of the VDR gene. Primers used for PCR ampliﬁcation of the
fragments are shown in Table 1. Allele types, single nucleotide
polymorphism reference numbers and PCR conditions for all
the analysed polymorphisms are shown in Table 2.
The ampliﬁed products were digested using restriction
enzymes; FokI, BsmI, ApaI and TaqI (all Promega Corp.,
Madison, WI, USA) according to manufacturer’s instructions.
Brieﬂy, 7 lL of each related PCR product was mixed with
0.5 lL of each restriction enzyme, 2.5 lL of 109 buffers,
0.5 lL bovine serum albumin and 14.5 lL H2O. After incuba-
tion at 37°C for 2 h, the restriction fragments were separated
by electrophoresis on a 2.5% agarose gel, stained with
ethidium bromide, and visualized with a 312-nm ultraviolet
transilluminator.
The usual nomenclature for restriction fragment length
polymorphism alleles was used in this study [26]. The lower
case allele represents the presence of the restriction site (f, b,
TABLE 1. PCR primers designed to amplify fragments harbouring the vitamin D receptor single nucleotide polymorphisms
(SNPs)
SNP Primer Sequence Fragment size
ApaI Forward 50-CAG AGC ATG GAC AGG GAG CAA-30 740 bp uncleaved
Reverse 30-GCA ACT CCT CAT GGC TGA GGT CTC-50 530 bp, 210 bp
BsmI Forward 50-CAA CCA AGA CTA CAA GTA CCG CGT CAG TGA-30 825 bp uncleaved
Reverse 30-AAC CAG CGG GAA GAG GTC AAG GG-50 650 bp, 175 bp
FokI Forward 50-AGC TGG CCC TGG CAC TGA CTC TGC TCT-30 265 bp uncleaved
Reverse 30-ATG GAA ACA CCT TGC TTC TTC TCC CTC-50 196 bp, 69 bp
TaqI Forward 50-CAG AGC ATG GAC AGG GAG CAA-30 740 bp uncleaved
Reverse 30-GCA ACT CCT CAT GGC TGA GGT CTC-50 495 bp, 245 bp or 290 bp, 245 bp, 205 bp
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a, t) and the uppercase allele represents the absence of the
restriction site (F, B, A, T).
Statistical analysis
Statistical analysis was based on contingency tables, including
calculations of OR and of the lower and upper limits of the
95% CI. The two-tailed Fisher’s exact test was applied to
determine whether distributions of categorized variables
between the groups were signiﬁcant. The Hardy–Weinberg
equilibrium was tested by comparing expected and observed
genotype frequencies by chi-square test. The conventional
level of p <0.05 was considered to be signiﬁcant.
Ethics
The study has been approved by the institutional review board
of the University Hospital and written informed consents were
obtained from all patients.
Results
One hundred and seventy-three individuals, 106 (61.3%)
women, with a median age of 68.5 (43–91) years, and duration
of T2D from diagnosis ranging from 0.1 to 40.0 (mean 9.4,
median 6.0) years have been enrolled in the study.
In the initial nasal swab sampling, 34/173 individuals (19.7%)
were found to be colonized by S. aureus. Among the 162
individuals from whom a second nasal sample for culture was
obtained, 14 (8.6%) were deﬁned as persistent carriers, 10
(6.2%) as intermittent S. aureus carriers and 138 (85.2%) as
non-carriers.
VDR gene ApaI a allele (T?G transition in intron 8), BsmI b
allele (G?A transition), FokI f allele (C?T transition at the
junction of intron 1 and exon 2) and TaqI t allele (silent T?C
transition in exon 9) genotypes and allele frequencies were
investigated in all 173 patients and are shown in Tables 1 and 2.
Staphylococcus aureus nasal colonizationwasmore common in
individuals with the FokI f allele than the F allele (p 0.05; OR 1.69,
95%CI 1.00–2.89). Individuals with a FokI ff genotypeweremore
frequently colonized than those with FokI FF and Ff genotypes
combined (p 0.03; OR 2.61, 95% CI 1.14–5.99) (Table 3).
As shown in Table 4, the presence of the FokI f allele was
related to higher rates of S. aureus persistent colonization
(p 0.002; OR 3.53, 95% CI 1.56–7.98), and FokI ff homozygotes
were more persistent carriers than FokI FF and Ff genotypes
combined (p <0.001; OR 7.32, 95% CI 2.39–22.41). The
signiﬁcant association found between FokI polymorphism in the
VDR gene and persistent nasal carriage of S. aureus in
individuals with T2D was independent of other common risk
factors of persistent carriage such as age, sex and time
between ﬁrst and second nasal swab culture, as shown by
linear regression analysis.
About 10% of the samples were ampliﬁed twice to check
the accuracy of the genotyping results and were found to be
100% identical to those of the ﬁrst genotyping attempt.
Discussion
The present study suggests that FokI polymorphism in the VDR
gene is associated with colonization and persistent nasal
carriage of S. aureus in individuals with T2D. FokI restriction
fragment length polymorphism is a truly functional polymor-
phism and can be considered as an independent marker in the
VDR gene, which can explain the association observed [3]. BsmI,
TaqI and ApaI VDR gene polymorphisms, which are non-func-
tional single nucleotide polymorphisms, were not associated
with S. aureus nasal colonization in the present study.
Staphylococcus aureus is an important human pathogen. Nasal
carriage of S. aureus is associated with increased risk of infection
[17,18]. A patient classiﬁed as a carrier could either be a
persistent carrier or an intermittent carrier. This distinction is
important because persistent carriers have higher S. aureus
loads and a higher risk of acquiring S. aureus infection [17].
The rates of overall colonization and persistent S. aureus
nasal carriage in this study were 17.4% and 11%, respectively,
TABLE 2. Allele types, single nucleotide polymorphism (SNP) reference numbers, and PCR conditions
SNP Allele type Ref. number PCR conditions
ApaI a allele: T?G transition
in intron 8
rs7975232 Denaturation at 94°C for 5 min, followed by addition of the polymerase, and then samples were exposed to 30 cycles of
denaturing (at 94°C for 60 s), annealing (at 60°C for 60 s), and chain extension (at 72°C for 1 min), followed by a ﬁnal
extension step at 72 8°C for 7 min
BsmI b allele: G?A transition rs1544410 Initial heating at 94°C for 4 min, followed by addition of the polymerase and then 35 cycles of denaturing
(at 94°C for 20 s),
annealing (at 60°C for 30 s), and chain extension (at 72°C for 30 s), followed by a ﬁnal extension step at 72°C for
7 min
FokI f allele: C ? T transition
at the junction of intron
1 and exon 2
rs10735810 Initial heating at 94°C for 5 min, followed by 35 cycles of denaturing (at 94°C for 20 s), annealing (at 60°C for 30 s),
and chain extension (at 72°C for 30 s), followed by a ﬁnal extension step at 72°C for 7 min
TaqI t allele: silent T?C
transition in exon 9
rs731236 Denaturation at 94°C for 5 min, followed by addition of the polymerase, and then samples were exposed to 30 cycles of
denaturing (at 94°C for 60 s), annealing (at 60°C for 60 s), and chain extension (at 72°C for 1 min), followed by a ﬁnal
extension step at 72°C for 7 min
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and were consistent with the ranges reported elsewhere
[17,27–30].
Why some individuals are more susceptible to S. aureus
nasal colonization than others and which factors are respon-
sible, have not yet been clariﬁed [29].
In vitro studies have shown that S. aureus is able also to
resist certain cationic antimicrobial peptides including
defensins and cathelicidin, which are present in nasal
secretions. Current evidence suggests that antimicrobial
peptide resistance of S. aureus is of minor importance
[17,31] and that other host factors such as DEFB1 promoter
polymorphism, which may promote persistent S. aureus
colonization by altering b-defensin expression, may be more
important [32].
The relationship between poor glycaemic control and
S. aureus carriage in patients with diabetes might be the result
of the reduced phagocytic activation due to hyperglycaemia.
On the other hand the discovery of speciﬁc receptors for 1,25
(OH)2D3 in pancreatic b cells and cells of the immune system
has expanded the role of vitamin D in glucose metabolism and
the immune system [1–4]. In this context, VDR single
nucleotide polymorphisms via poor glycaemic control might
contribute to S. aureus carriage.
Although the contribution of vitamin D to the host response
is not fully elucidated, vitamin D metabolites are known to have
immunomodulatory properties [1–4]. VDRs have been identi-
ﬁed in almost all cells of the immune system, especially
macrophages, dendritic cells and activated T lymphocytes [1–
3]. These cells contain the enzyme 1a-hydroxylase, which is
necessary for the conversion of vitamin D3 to the metabolically
active molecule 1,25(OH)2D3 [1,2]. The 1a-hydroxylase pres-
ent in immune cells is identical to that of the renal enzyme, but
regulation of its expression and activity is different. The
macrophage enzyme is regulated by immune signals. In vitro,
1,25(OH)2D3 stimulates the phagocytosis and killing of bacteria
by macrophages. In general, 1,25(OH)2D3 enhances the innate
immune response primarily via its ability to stimulate antimi-
crobial peptides including cathelicidin, an important antimicro-
bial peptide, against invading pathogens [2].
In contrast, 1,25(OH)2D3 also has a direct inhibitory effect
on antigen presentation, T-cell proliferation and cytokine
secretion by macrophages [1,2]. Therefore, vitamin D metab-
olites express their immunomodulatory function by acting via
the VDR to stimulate macrophages [1,2].
Polymorphisms of the VDR gene have been suggested to be
involved in the development of T2D [1–3]. An association
TABLE 3. Distribution of vitamin D receptor (VDR) genotype and allele frequencies in 173 individuals with type 2 diabetes as










n = 139 p-valueb OR (95% CI)b
FokI
Genotype
ff 0.14 12 (35.3) 24 (17.3) 0.03 2.61 (1.14–5.99)c
Ff 12 (35.3) 63 (45.3)
FF 10 (29.4) 52 (37.4)
Allele
F 0.14 32 (47.1) 167 (60.1) 0.05 1.69 (1.00–2.89)d
f 36 (52.9) 111 (39.9)
BsmI
Genotype
bb 0.38 8 (23.5) 43 (30.9) NS
Bb 19 (55.9) 72 (51.8)
BB 7 (20.6) 24 (17.3)
Allele
B 0.38 33 (48.5) 120 (43.2) NS
b 35 (51.5) 158 (56.8)
ApaI
Genotype
aa 0.26 5 (14.7) 32 (23.0) NS
Aa 17 (50.0) 61 (43.9)
AA 12 (35.3) 46 (33.1)
Allele
A 0.26 41 (60.3) 153 (55.0) NS
a 27 (39.7) 125 (45.0)
TaqI
Genotype
tt 0.72 7 (20.6) 19 (13.7) NS
Tt 10 (29.4) 75 (53.9)
TT 17 (50.0) 45 (32.4)
Allele
T 0.72 44 (64.7) 165 (59.4) NS
t 24 (35.3) 113 (40.6)
NS, not signiﬁcant.
aHardy–Weinberg equilibrium (calculations with one degree of freedom).
bp-values and ORs calculated for colonized versus non-colonized type 2 diabetes individuals.
cFokI ff versus (FokI FF + FokI Ff).
df allele versus F allele.
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between VDR gene polymorphisms and susceptibility to
infections has also been described [5,8–16]. ApaI genotype
has been shown to modulate the susceptibility to Mycobacte-
rium malmoense [8] and hepatitis B virus [9]. TaqI genotype has
been suggested to modulate the susceptibility to Mycobacte-
rium malmoense and Mycobacterium leprae [8], lower respira-
tory tract infections in early childhood [10] and periodontitis,
although the precise role of the t allele in different manifes-
tations of the disease remains controversial [11,12]. In the
present study, the presence of the FokI f allele and individuals
with a FokI ff genotype were related to higher rates of S. aureus
persistent colonization.
Interestingly, in a large study with healthy volunteers, no
signiﬁcant association between VDR gene polymorphism and
S. aureus nasal carriage status has been demonstrated [33].
Therefore this study provides evidence that in patients with
diabetes, the genetic–environmental interactions are needed
for S. aureus carriage phenotype in the presence of certain
VDR gene single nucleotide polymorphisms.
Apart from the differences in clinical manifestations and
disease course of T1D and T2D and the different genetic
susceptibility loci detected so far, increasing evidence high-
lighting a partial genetic overlap between these diseases has
emerged, regarding some common HLA loci as well as an
intron 4 eNOS polymorphism [34,35]. These data strengthen
the assumption that these diseases might share a common
genetic origin and cause different phenotypes in different
periods of life. Notably, the TaqI and ApaI VDR gene
polymorphisms that were reported to be associated with nasal
carriage of S. aureus in individuals with T1D who originated
from the same geographic region as our cohort, were not
found in the current study to be associated with persistent
nasal carriage of S. aureus in individuals with T2D. Therefore
the observation of different single nucleotide polymorphisms in
the VDR gene being associated with S. aureus carriage in T1D
compared with T2D is evidence against a causal relation of VDR
single nucleotide polymorphisms and S. aureus.
The most important limitation of the study is the relatively
small sample size. Larger studies would produce more
deﬁnitive results, but it should be pointed out that we focused
on individuals with T2D in a restricted but genetically
homogeneous population. It would be interesting to conﬁrm
these preliminary ﬁndings in a larger cohort of patients of
different origin.
In conclusion, this study suggests, for the ﬁrst time, that
VDR gene polymorphisms affect nasal colonization by S. aureus
TABLE 4. Distribution of vitamin D receptor (VDR) genotype and allele frequencies in 162 individuals with type 2 diabetes as












n = 138 p-valueb OR (95% CI)b
FokI
Genotype
ff 0.14 9 (64.3) 1 (10.0) 24 (17.4) <0.001 7.32 (2.39–22.41)c
Ff 2 (14.3) 6 (60.0) 62 (44.9)
FF 3 (21.4) 3 (30.0) 52 (37.7)
Allele
F 0.14 8 (28.6) 12 (60.0) 166 (60.1) 0.002 3.53 (1.56–7.98)d
f 20 (71.4) 8 (40.0) 110 (39.9)
BsmI
Genotype
bb 0.72 3 (21.4) 5 (50.0) 42 (30.4) NS
Bb 7 (50.0) 3 (30.0) 72 (52.2)
BB 4 (28.6) 2 (20.0) 24 (17.4)
Allele
B 0.72 15 (53.6) 7 (35.0) 120 (43.5) NS
b 13 (46.4) 13 (65.0) 156 (56.5)
ApaI
Genotype
aa 0.15 4 (28.6) 1 (10.0) 32 (23.2) NS
Aa 5 (35.7) 6 (60.0) 60 (43.5)
AA 5 (35.7) 3 (30.0) 46 (33.3)
Allele
A 0.15 15 (53.6) 12 (60.0) 152 (55.1) NS
a 13 (46.4) 8 (40.0) 124 (44.9)
TaqI
Genotype
tt 0.45 3 (21.4) 1 (10.0) 19 (13.8) NS
Tt 2 (14.3) 5 (50.0) 75 (54.3)
TT 9 (64.3) 4 (40.0) 44 (31.9)
Allele
T 0.45 20 (71.4) 13 (65.0) 163 (59.1) NS
t 8 (28.6) 7 (35.0) 113 (40.9)
NS, not signiﬁcant.
aHardy–Weinberg equilibrium (calculations with one degree of freedom).
bp-values and ORs calculated for persistent versus intermittent plus non-carriage state
cFokI ff versus (FokI FF + FokI Ff).
df allele versus F allele.
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in patients with T2D, and further contribute to the under-
standing of the immunoregulatory role of vitamin D in host
response and susceptibility to infection. However, because of
the relatively small number of samples analysed, the results
should be evaluated with caution. Future studies are warranted
to include functional tests on immune cells and focus on
underlying mechanisms and on genetic and environmental
factors potentially interfering in the relationship between VDR
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